Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530004) titled 'Factors related to length of stay of critical ill patients (ESI level 1, 2)... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530002) titled 'Comparing the immediate and sustained therapeutic effects of simultaneous a... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530009) titled 'Continuous versus extended infusion of meropenem in pediatric sepsis' on Ma... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530006) titled 'Oxygen consumption and hemodynamic response during stretching or eccentric ... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530003) titled 'Effectiveness of Ginger on Preventing Postoperative Ileus after Cesarean Se... Read More
Geneva, June 8 -- International Clinical Trials Registry received information related to the study (TCTR20260530001) titled 'Sequential Therapy with Docetaxel and Abiraterone Acetate in Castration-Res... Read More
Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061746) titled 'HR of PFS as surrogate endpoints for HR of OS in RCTs of systemic immuno-the... Read More
Singapore, May 29 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More
Singapore, May 29 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More
Singapore, May 29 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More